Cargando…
Vaccine hesitancy: the next challenge in the fight against COVID-19
Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires co...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851308/ https://www.ncbi.nlm.nih.gov/pubmed/32785815 http://dx.doi.org/10.1007/s10654-020-00671-y |
_version_ | 1784652795312340992 |
---|---|
author | Dror, Amiel A. Eisenbach, Netanel Taiber, Shahar Morozov, Nicole G. Mizrachi, Matti Zigron, Asaf Srouji, Samer Sela, Eyal |
author_facet | Dror, Amiel A. Eisenbach, Netanel Taiber, Shahar Morozov, Nicole G. Mizrachi, Matti Zigron, Asaf Srouji, Samer Sela, Eyal |
author_sort | Dror, Amiel A. |
collection | PubMed |
description | Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates. |
format | Online Article Text |
id | pubmed-8851308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-88513082022-02-18 Vaccine hesitancy: the next challenge in the fight against COVID-19 Dror, Amiel A. Eisenbach, Netanel Taiber, Shahar Morozov, Nicole G. Mizrachi, Matti Zigron, Asaf Srouji, Samer Sela, Eyal Eur J Epidemiol Vaccine Hesitancy Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates. Springer Netherlands 2020-08-12 2020 /pmc/articles/PMC8851308/ /pubmed/32785815 http://dx.doi.org/10.1007/s10654-020-00671-y Text en © Springer Nature B.V. 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Vaccine Hesitancy Dror, Amiel A. Eisenbach, Netanel Taiber, Shahar Morozov, Nicole G. Mizrachi, Matti Zigron, Asaf Srouji, Samer Sela, Eyal Vaccine hesitancy: the next challenge in the fight against COVID-19 |
title | Vaccine hesitancy: the next challenge in the fight against COVID-19 |
title_full | Vaccine hesitancy: the next challenge in the fight against COVID-19 |
title_fullStr | Vaccine hesitancy: the next challenge in the fight against COVID-19 |
title_full_unstemmed | Vaccine hesitancy: the next challenge in the fight against COVID-19 |
title_short | Vaccine hesitancy: the next challenge in the fight against COVID-19 |
title_sort | vaccine hesitancy: the next challenge in the fight against covid-19 |
topic | Vaccine Hesitancy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851308/ https://www.ncbi.nlm.nih.gov/pubmed/32785815 http://dx.doi.org/10.1007/s10654-020-00671-y |
work_keys_str_mv | AT droramiela vaccinehesitancythenextchallengeinthefightagainstcovid19 AT eisenbachnetanel vaccinehesitancythenextchallengeinthefightagainstcovid19 AT taibershahar vaccinehesitancythenextchallengeinthefightagainstcovid19 AT morozovnicoleg vaccinehesitancythenextchallengeinthefightagainstcovid19 AT mizrachimatti vaccinehesitancythenextchallengeinthefightagainstcovid19 AT zigronasaf vaccinehesitancythenextchallengeinthefightagainstcovid19 AT sroujisamer vaccinehesitancythenextchallengeinthefightagainstcovid19 AT selaeyal vaccinehesitancythenextchallengeinthefightagainstcovid19 |